Written Question · S1W-11382 · Session 1
Further to the answer to question S1W-9430 by Susan Deacon on 15 September 2000 and the Scottish Needs Assessment Programme report on multi…
The question
To ask the Scottish Executive, further to the answer to question S1W-9430 by Susan Deacon on 15 September 2000 and the Scottish Needs Assessment Programme report on multiple sclerosis (MS), and in the light of the relatively high incidence of MS in Scotland, whether it will advise the Chief Scientist Office to reconsider not contributing to Scottish, UK or European studies into MS treatment.
The answer
I refer the member to the answer given to question S1W-11381 on 1 December 2000.
In the Official Report
No contribution in the Official Report cites S1W-11382 by reference.